BIO-Europe Spring® 2017: Digimed and diagnostics: Market access and new collaborations

April 6, 2017

The effect of digital medicine on diagnostics is having and will continue to have a revolutionary effect on the interactions between patients and their healthcare providers and between the healthcare system and its service and support providers. While these changes herald more streamlined and to some extent personalized treatments for patients, the dynamic of these relationships will also have profound effects on treatment decisions. We examine the factors digital medicine companies face in gaining market access.

 

Click here for more coverage of the activities held during BIO-Europe Spring

Previous Video
BIO-Europe Spring® 2017:  Infant Bacterial Therapeutics harnesses microbiome to treat preterm babies
BIO-Europe Spring® 2017: Infant Bacterial Therapeutics harnesses microbiome to treat preterm babies

By harvesting Lactobacillus reuteri from lactating mothers, Infant Bacterial Therapeutics has developed an ...

Next Video
BIO-Europe Spring® 2017: Incorporating flexibility into your R&D strategy
BIO-Europe Spring® 2017: Incorporating flexibility into your R&D strategy

Strategic decisions made early in clinical development often have an impact on the downstream commercial po...